Internal Medicine · Opelousas, LA
NPI
1003990656
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
3975 I-49 S Services Rd, Suite 200
Opelousas, LA, 70570
Phone (337) 594-0750
Groups this clinician bills Medicare through
Medicare paid, 2024
$216K
3,082 services
Medicare patients, 2024
487
Average age 71
Drug cost, 2024
$2.4M
18,273 prescriptions
Company payments, 2025
$824
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Fernando Alemany was code 99214 (office e&m - established), 1,124 times for 317 patients. In total Fernando Alemany billed 3,082 services in 42 codes, and Medicare paid $216K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,124 | 317 | $78.35 | $88K |
| 99233 Hospital E&M - Subsequent | Facility | 483 | 125 | $87.80 | $42K |
| 99232 Hospital E&M - Subsequent | Facility | 443 | 73 | $56.37 | $25K |
| 99213 Office E&M - Established | Office | 252 | 150 | $54.24 | $14K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 180 | 29 | $0.08 | $15.02 |
| 99223 Hospital E&M - Initial | Facility | 145 | 123 | $123.05 | $18K |
| 96372 Injection Administration | Office | 76 | 34 | $9.33 | $709 |
| 99407 Behavioral Health Services | Office | 76 | 39 | $23.90 | $1,816 |
| 99239 Hospital Discharge Management | Facility | 68 | 57 | $81.82 | $5,564 |
| 99215 Office E&M - Established | Office | 62 | 54 | $111.07 | $6,886 |
| 99205 Office E&M - New | Office | 34 | 34 | $134.85 | $4,585 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 25 | 25 | $119.95 | $2,999 |
| 99407 Behavioral Health Services | Facility | 19 | 18 | $23.34 | $443 |
| G0179 Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 12 | 11 | $30.44 | $365 |
By year: 2022 $316K for 4,713 services; 2023 $215K for 3,194 services; 2024 $216K for 3,082 services.
Medicare prescription drug claims, 2024
In 2024, the drug Fernando Alemany prescribed most often to Medicare patients was Levothyroxine Sodium, with 629 prescriptions and refills. In total Fernando Alemany wrote 18,273 Medicare prescriptions that cost $2.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 629 | 1,032 | 107 | $5,135 |
| Atorvastatin Calcium Generic | 524 | 1,018 | 117 | $5,343 |
| Pantoprazole Sodium Generic | 522 | 987 | 130 | $4,839 |
| Gabapentin Generic | 438 | 553 | 75 | $5,555 |
| Amlodipine Besylate Generic | 425 | 815 | 97 | $2,923 |
| Rosuvastatin Calcium Generic | 423 | 768 | 82 | $4,067 |
| Metformin Hcl Generic | 369 | 706 | 75 | $1,801 |
| Furosemide Generic | 337 | 519 | 63 | $1,039 |
| Simvastatin Generic | 302 | 650 | 68 | $2,421 |
| Potassium Chloride Generic | 289 | 417 | 52 | $2,813 |
| Benazepril Hcl Generic | 284 | 633 | 62 | $2,657 |
| Omeprazole Generic | 271 | 454 | 52 | $2,227 |
| Trazodone Hcl Generic | 270 | 452 | 64 | $1,967 |
| Lisinopril Generic | 230 | 370 | 42 | $2,195 |
| Eliquis Apixaban | 216 | 251 | 31 | $104K |
Brand drugs: 2,708 claims; generic drugs: 15,480 claims; opioid claims: 331.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Fernando Alemany $824 ($824 in general payments such as food, travel and fees) from 11 companies. The largest payer was Salix Pharmaceuticals, a division of Bausch Health US, LLC with $204.
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 18 | $204 |
| Abbvie Inc. ABBV | 16 | $173 |
| Merck Sharp & Dohme LLC MRK | 6 | $118 |
| Lilly USA, LLC LLY | 3 | $75.15 |
| Amgen Inc. AMGN | 1 | $59.01 |
| Ardelyx, Inc. ARDX | 3 | $54.4 |
| Corcept Therapeutics CORT | 2 | $44.76 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 2 | $39.29 |
| Novo Nordisk Inc NVO | 1 | $21.64 |
| Exact Sciences Corporation EXAS | 1 | $17.02 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.